Dr. Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on April 25, 2025, recommended Final Dividend of Rs. 6 per equity share.
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Smallcap 250 and 0.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Dr. Lal Path Labs Ltd., at its meeting held on April 25, 2025, has recommended a Final Dividend of Rs. 6 per equity share for the financial year. This is a routine post-board-meeting disclosure informing shareholders of the dividend recommendation. The final dividend is subject to approval by the shareholders at the upcoming Annual General Meeting. The record date and book closure dates will be announced separately by the company.
Shareholders will receive Rs. 6 per share as dividend once approved, providing a modest income on holdings. Given the company's typically higher share price, the dividend yield is likely to be on the lower side, so the price impact is expected to be limited.